RPAM
AUXL

Rhenman & Partners Asset Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-63,875
Closed -$1.74M – 106
2014
Q1 		$1.74M Sell
63,875
-21,125
-25% -$561K 0.52% 68
2013
Q4 		$1.76M Buy
+85,000
New +$1.6M 0.69% 63

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Rhenman & Partners Asset Management's AUXL Position: Q2 2014 in Review

Rhenman & Partners Asset Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q2 2014, closing a stake of 63,875 shares — an estimated $1.74M sold.

Rhenman & Partners Asset Management first reported a position in AUXL in Q4 2013 and held it in 2 quarters. The position peaked at $1.76M in Q4 2013. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Rhenman & Partners Asset Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 63,875 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $1.74M.
  • Rhenman & Partners Asset Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Rhenman & Partners Asset Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $1.76M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2014, filed 31 Jul 2014.